Edition:
United Kingdom

Biofrontera AG (B8FGn.DE)

B8FGn.DE on Xetra

5.47EUR
21 Mar 2019
Change (% chg)

-- (--)
Prev Close
€5.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,646
52-wk High
€6.90
52-wk Low
€4.78

Chart for

About

Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and... (more)

Overall

Beta: -0.01
Market Cap(Mil.): €139.64
Shares Outstanding(Mil.): 38.42
Dividend: --
Yield (%): --

Financials

  B8FGn.DE Industry Sector
P/E (TTM): -- 29.30 32.54
EPS (TTM): -0.46 -- --
ROI: -184.45 14.23 13.82
ROE: -276.38 15.46 15.25

Earnings vs. Estimates